CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported second quarter 2015 financial results.
Revenue for the second quarter of 2015 was $7.6 million, an increase of 17% over the prior year period. During the quarter, 29 additional XT-8 analyzers were placed in end-user laboratories, resulting in a total installed base of 591 analyzers within the U.S. market.
Help employers find you! Check out all the jobs and post your resume.
Revenue for the second quarter of 2015 was $7.6 million, an increase of 17% over the prior year period. During the quarter, 29 additional XT-8 analyzers were placed in end-user laboratories, resulting in a total installed base of 591 analyzers within the U.S. market.
Help employers find you! Check out all the jobs and post your resume.
